Major Adverse Cardiovascular Events Related to Jak Inhibitors: A Disproportionality Analysis Using WHO Global Individual Case Safety Database
Langue
EN
Communication dans un congrès
Ce document a été publié dans
Drug Safety, 23rd Annual Meeting of the Global Perspectives on Pharmacovigilance in the Digital Age and Advanced Therapeutics (ISoP), 2024-10-01, Montréal. 2024-12-01, vol. 47, n° 12, p. 1395-1395
Unités de recherche